ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer

Clinical trial NCT06498479 · RECRUITING

Trial details

NCT number: NCT06498479
Sponsor: Hansoh BioMedical R&D Company
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2024-07-04
Primary completion: 2026-09-30
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.